Skip to main content

Table 1 Antimicrobial susceptibility of staphylococci isolated from food and clinical samples

From: Emerging of antimicrobial resistance in staphylococci isolated from clinical and food samples in Algeria

Antibiotic agent

Food isolates (n = 51)

Clinical isolates (n = 45)

Hospital acquired isolates (n = 18)

Community acquired isolates (n = 27)

S. aureus (n = 33)

CoNS (n = 18)

S. aureus (n = 18)

S. aureus (n = 21)

CoNS (n = 06)

S rate (%)

R rate (%)

I rate (%)

S rate (%)

R rate (%)

I rate (%)

S rate (%)

R rate (%)

I rate (%)

S rate (%)

R rate (%)

I rate (%)

S rate (%)

R rate (%)

I rate (%)

P (10UI)

0.00

100.00

0.00

16.67

83.33

0.00

5.56

94.44

0.00

9.52

90.48

0.00

50.00

50.00

0.00

OX (1 μg)

93.94

6.06

0.00

83.33

16.67

0.00

61.11

38.89

0.00

33.33

66.67

0.00

66.67

16.67

16.67

FOX (30 μg)

93.94

6.06

0.00

83.33

16.67

0.00

61.11

38.89

0.00

47.62

52.38

0.00

83.33

16.67

0.00

AMC (20/10 μg)

100.00

0.00

0.00

94.44

5.56

0.00

94.44

5.56

0.00

80.95

19.05

0.00

83.33

16.67

0.00

GM (10 μg)

100.00

0.00

0.00

100.00

0.00

0.00

94.44

0.00

5.56

85.71

14.29

0.00

83.33

16.67

0.00

E (15 μg)

81.82

9.09

9.09

55.56

27.78

16.67

72.22

27.78

0.00

47.62

52.38

0.00

66.67

16.67

16.67

K (30 μg)

54.55

9.09

36.36

83.33

11.11

5.56

66.67

27.78

5.56

85.71

14.29

0.00

83.33

16.67

0.00

TE (30 μg)

54.55

45.45

0.00

44.44

55.56

0.00

55.56

44.44

0.00

47.62

52.38

0.00

50.00

50.00

0.00

VA (30 μg)

96.97

3.03

0.00

100

0.00

0.00

100.00

0.00

0.00

100.00

0.00

0.00

100.00

0.00

0.00

CL (2 μg)

90.91

6.06

3.03

61.11

33.33

5.56

94.44

0.00

5.56

95.24

0.00

4.76

100.00

0.00

0.00

RIF (5 μg)

96.97

3.03

0.00

88.89

11.11

0.00

88.89

11.11

0.00

85.71

9.52

4.76

100.00

0.00

0.00

STX (1.25/23.75 μg)

100.00

0.00

0.00

83.33

5.56

11.11

100.00

0.00

0.00

80.95

14.29

4.76

83.33

0.00

16.17

  1. P penicillin, OX oxacillin, FOX cefoxitin, AMC amoxicillin + clavulanic acid, GM gentamicin, E erythromycin, K kanamycin, TE tetracycline, VA vancomycin, CL clindamycin, RIF rifampicin, STX trimethoprim/sulfamethoxazole, S susceptible, R resistant, I intermediate